A total of 724 active diabetic patients were identified in October 2009 (pre-implementation) and 731 active diabetic
patients were identified in June 2011(post-implementation) with their characteristics as showed in Table
1. Process outcomes with blood pressure measured in the past 6 months (p-value 0.77) and LDL cholesterol
measured in past 12 months (p-value 0.63) did not show any change in contrary to hemoglobin A1C in past 6
months (p-value 0.02) and urine microalbumin in the past 6 months (p-value 0.01) showed statistically significant
improvement (Table 2). Quality outcomes as blood pressure less than 140/90 (p-value 0.17), most recent
hemoglobin A1C less than 7% (p-value 0.10), most recent LDL cholesterol less than 100 (p-value 0.64) did not
show any improvement (Table 3).